A Response To: Sodium–Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions
Crossref DOI link: https://doi.org/10.1007/s13300-020-00943-6
Published Online: 2020-10-14
Published Print: 2020-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bossi, Antonio C. http://orcid.org/0000-0001-8900-1787
Forloni, Franco
Colombelli, Paolo L.
Text and Data Mining valid from 2020-10-14
Version of Record valid from 2020-10-14
Article History
Received: 30 September 2020
Accepted: 3 October 2020
First Online: 14 October 2020